Transpek Industry Limited · BSE:TRANSPEK

Transpek Industry — Investor Presentation (November 2022)

40 slides from Transpek Industry's investor presentation, November 2022

  1. Slide 1: Investor Presentation submission letter to BSE

    +91 265 6700 300 PHONE Transpek, Industry limited vTranspel\ � Reg. Office: 4th Floor, Ulleria 1038 Gotri - Sevasl Road rea1ive Chemlsrry Vadodara - 390021. GuIarat. (India) Date: 26th November, 2022 To, BSE Limited P.J. Towers, Dalal Street, Mumbai -400 001 Ref: Scrip Code: 506687 Subject: Investor

  2. Slide 2: Transpek Industry Limited Investor Presentation November 2022

    Transpek Industry Limited Investor Presentation November 2022

  3. Slide 3: Safe Harbour

    Safe Harbour This presentation and the accompanying slides (the “Presentation”), which have been prepared by Transpek Industry Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any se

  4. Slide 4: Q2 & H1 FY23 - Financial Highlights

    Q2 &H1 FY23 - Financial Highlights

  5. Slide 5: Business Highlights (1/2)

    Business Highlights (1/2) • Company registered good quarterly and half-yearly performances with total revenue of Rs 221 crores for Q2FY23 and Rs 436 crores for H1FY23. Higher realization, rising demand from the end application market, and a better product mix have boosted business performance during

  6. Slide 6: Business Highlights (2/2)

    Business Highlights (2/2) • We have primary approval for adding 450 metric tons per month of alkyl and acid chloride, but we can only add up to 250 metric tons due to the current effluent or emission level norms. We are awaiting the final approval from regulatory and expected to get a nod in the com

  7. Slide 7: Performance Highlights

    Performance Highlights Q2 FY23 Sales Distribution based on Revenue* (Rs. In Cr) Application +39% 14.0% Polymer 215.8 220.6 10.0% Pharma 190.6 57.0% Specialty 158.4 19.0% 146.5 Others Q2 FY23 - Revenue Breakup Q2 FY22 Q3 FY22 Q4FY22 Q1FY23 Q2 FY23 12.0% International EBITDA* (Rs. In Cr) PAT (Rs. In C

  8. Slide 8: Performance Highlights

    Performance Highlights H1 FY23 Sales Distribution based on Revenue* (Rs. In Cr) Application +50% 16.4% Polymer 436.4 Pharma 10.2% 58.0% Specialty 15.4% 290.4 Others H1 FY23 - Revenue Breakup H1 FY22 H1 FY23 16.0% International EBITDA* (Rs. In Cr) PAT (Rs. In Cr) Margin Domestic 21.5% 16.9% 10.7% 8.3

  9. Slide 9: Q2 & H1 FY23 - Consolidated Profit & Loss Account

    Q2 & H1 FY23 - Consolidated Profit & Loss Account Particulars (Rs. Crores) Q2 FY23 Q2 FY22 Y-o-Y H1 FY23 H1 FY22 Y-o-Y Revenue from Operations 216.2 154.7 427.7 276.4 Other Income 4.4 3.8 8.7 14.0 Total Revenue from operations 220.6 158.4 39.2% 436.4 290.4 50.2% Cost of materials consumed 115.6 90.8

  10. Slide 10: Sep'22 - Consolidated Balance Sheet

    Sep’22 - Consolidated Balance Sheet Liabilities (Rs. Crores) Sep-22 Mar-22 Assets (Rs. Crores) Sep-22 Mar-22 Equity Non Current assets Equity Share capital 5.6 5.6 Property, Plant and Equipment 290.1 287.1 Other Equity 515.3 478.7 Capital work-in-progress 23.8 16.1 Right to use of lease assets 58.5

  11. Slide 11: Sep'22 - Consolidated Cash Flow Statement

    Sep’22 - Consolidated Cash Flow Statement Particulars (Rs. Crores) Sep-22 Sep-21 Net Profit Before Tax 48.8 43.0 Adjustments for: Non Cash Items / Other Investment or Financial Items 27.8 21.4 Operating profit before working capital changes 76.7 64.4 Changes in working capital -19.8 -6.7 Cash genera

  12. Slide 12: FAQ's

    FAQ’s • The Capex for next two years will be based on the timing of the introduction of new products and any significant investment will be announced appropriately. Capex • It is proposed to replace an existing old plant with a new plant of about 70% higher capacity. This would help capture higher d

  13. Slide 13: Transpek at Glance

    Transpek at Glance

  14. Slide 14: About us

    About us Environment Protection Founded by Shri. Govindji Shroff in 1965 Over 5 decades Creative Over three Part of Excel experience in Chemistry decades of presence in the group of Sulphur and international companies Chlorine market Chemistry Customer Exploring every Headquartered Focus possible in

  15. Slide 15: Our journey over five decades

    Our journey over five decades 2017 Long term supply agreement with global chemical giant 2018 Started supplying under long 2004 term supply agreement and Set up of First Multi Purpose became big global player in acid Acid Chloride Plant chlorides 2012 1987 Significant strategic shift from Started ma

  16. Slide 16: Our products are supplied to varied industries

    Our products are supplied to varied industries Leading global supplier for ‘Chlorinated Products’ to various industry sectors H1 FY23 Sales Distribution based on ranging from Pharmaceuticals, Agrochemicals and dyes to pigments. Application Polymers Pharma Specialty Chemicals 16.4% Polymer Pharma 15.

  17. Slide 17: Our products have multiple applications

    Our products have multiple applications Diversified Products Across India’s Fastest Growing Industries • 2, 4, 6 Trimethyl Benzoyl • 2-Methoxyethyl chloride • 2-Chloroethylamine • 2-Chloroethylamine Chloride • Cocoyl Chloride Hydrochloride Solution • 2-Propoxyethyl chloride Hydrochloride Solution •

  18. Slide 18: Our capabilities developed over years

    Our capabilities developed over years Research & Development Sustainability Ratings ◊ In house development of products ◊ ECOVADIS Sustainability platform – the company is ◊ DSIR approved R&D Facility rated very high with ‘Silver Badge’ ◊ R&D Lab approved by MS University of Baroda for ◊ One of those

  19. Slide 19: Our clients trust in our capabilities & chemistries

    Our clients trust in our capabilities & chemistries Company has built an excellent reputation globally – Testament to our Reliability and Trustworthiness Long-term supply agreement commenced from 1st January 2018 Contract 10 years Period Exclusive contract with a High performance product with dedica

  20. Slide 20: Our plants are multipurpose and multiproduct

    Our plants are multipurpose and multiproduct Ekalbara Located ~25 km away from the headquarter location at Vadodara, Gujarat. Dedicated multipurpose and multiproduct plants spread over 100 acres with total production capacity of 66,000 • Strategically located in largest chemical MTPA. manufacturing

  21. Slide 21: Our R&D facility is recognized by Government of India

    Our R & D facility is recognized by Government of India Research & Development Developed a comprehensive in-house R&D facility recognized by the Department of Science & Technology, Government of India, which is equipped with latest technology and equipment Every new and existing product undergoes a

  22. Slide 22: Our top management is committed to process safety

    Our top management is committed to process safety PHA Chemical Release • Process Hazard Analysis 01 • Dispersion Modeling Studies conducted for all products and • Storage Quantity Reduction processes 02 • Mechanical Integrity of Equipment Top Management 06 PSSR • Total commitment and • Pre-Startup s

  23. Slide 23: Our transportation is safe, systematic and sustainable

    Our transportation is safe, systematic and sustainable Logistics Safe, systematic and sustainable transportation is a key challenge to ever changing global chemical industry Pioneers in developing in-house ISO Tank station which is well equipped with state-of-the-art technology We manage over 600 IS

  24. Slide 24: Our products are delivered across the globe

    Our products are delivered across the globe H1 FY23 - Revenue Breakup One of the Pioneering Global Exporters from India since 1986 Long term relations with Leading Global Chemical Giants 16% Sweden 84% Spain Germany Russia France Italy Switzerland Domestic International U.S.A. Japan China South Kore

  25. Slide 25: Our board has vast industry experience

    Our board has vast industry experience Mr. Ashwin C. Shroff | Chairman Mr. Ninad D. Gupte | Independent Director He is a B.Sc degree from Bombay University, PGDBM (XLRI-Jamshedpur), and Diploma in He is a science graduate, Mr. Shroff have emerged stronger, helping the growth of Tax Management (Bajaj

  26. Slide 26: Our company has adopted a sustainable method of doing business

    Our company has adopted a sustainable method of doing business Community Empowerment Biodiversity Serving the society in various areas Maintaining and enhancing green belt (flora and like health & hygiene, education, skill fauna) within the factory premises through development, vocational training e

  27. Slide 27: ESG at the heart of all we do

    ESG at the heart of all we do

  28. Slide 28: Corporate social responsibility

    Corporate social responsibility Women Empowerment Workshops Vocational Training Understanding the needs of communities, addressing them Our vision is to actively contribute towards through need-based projects and making them work together creating innovative and sustainable solutions in to help crea

  29. Slide 29: Awards and Recognitions – A glimpse

    Awards and Recognitions – A glimpse Government of Gujarat: FGI Award for Excellence in the field of Indian Chemical Council: Excellence in CSR Award Environment Pollution Abatement & Best in Social Responsibility Award Preservation Shri Atul Shroff, Director & Union Leader Shri Shri Bimal V. Mehta,

  30. Slide 30: Environment, health and safety

    Environment, health and safety Rainwater harvesting and recharging Green cover in Transpek premise Safety is our responsibility We have Full-fledged Effluent management system with a licensed discharge facility to the central Effluent channel Our company has 100 acres of land with a green belt of mo

  31. Slide 31: Socially responsible at the time of COVID-19

    Socially responsible at the time of COVID – 19 Activities done during COVID-19: Arranged for immunity boosting medicines including multi vitamins, zinc and iron sucrose injections, as per the requirements of Primary Health Centre – Mujpur, along with gloves and sanitizer bottles for their health sta

  32. Slide 32: Historical Financial Highlights

    Historical Financial Highlights

  33. Slide 33: FY22 – Consolidated Profit & Loss Account

    FY22 – Consolidated Profit & Loss Account Particulars (Rs. Crores) FY22 FY21 Y-o-Y Revenue from Operations 599.1 339.4 Other Income 28.4 17.3 Total Revenue from operations 627.5 356.7 75.9% Cost of materials consumed 332.9 159.3 Purchases of stock-in-trade 0.0 0.0 Changes in inventories of finished

  34. Slide 34: Mar'22 - Consolidated Balance Sheet

    Mar’22 - Consolidated Balance Sheet Liabilities (Rs. Crores) Mar-22 Mar-21 Assets (Rs. Crores) Mar-22 Mar-21 Equity Non Current assets Equity Share capital 5.6 5.6 Property, Plant and Equipment 287.1 271.5 Other Equity 478.7 374.2 Capital work-in-progress 16.1 13.9 Right to use of lease assets 7.4 1

  35. Slide 35: Mar'22 - Consolidated Cash Flow Statement

    Mar’22 - Consolidated Cash Flow Statement Particulars (Rs. Crores) Mar-22 Mar-21 Net Profit Before Tax 84.2 25.5 Adjustments for: Non Cash Items / Other Investment or Financial Items 35.2 33.6 Operating profit before working capital changes 119.5 59.1 Changes in working capital -49.7 -20.9 Cash gene

  36. Slide 36: Consolidated Financial Highlights

    Consolidated Financial Highlights Revenue* (Rs. In Cr) EBITDA* (Rs. In Cr) PAT (Rs. In Cr) 15.3% 21.9% 23.2% 18.1% 19.8% 7.1% 10.7% 12.5% 6.5% 10.4% Margin 612.4 627.5 583.0 150 134.4 135.3 80 73.0 124.5 65.7 65.4 60 370.9 356.7 100 56.9 64.4 40 26.4 23.3 50 20 0 0 FY18 FY19 FY20 FY21 FY22 FY18 FY19

  37. Slide 37: Consistent Dividend Performance

    Consistent Dividend Performance Dividend Dividend Per Share 240 27 225% 220 200% 200 20.0 22.5 180 160 18 140 125% 120 100 90% 90% 12.5 80 75% 75% 9 9.0 9.0 60 50% 7.5 7.5 40 25% 5.0 20 2.5 0 0 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY22 36

  38. Slide 38: Way Forward

    Way Forward

  39. Slide 39: Strategic Growth

    Strategic Growth • While adding more Acid Chlorides, we have been focusing on other products that are under development at different stages. Once commercialized, these products shall provide further growth and reduce concentration on Acid Chlorides. • The Company has been working to expand its custo

  40. Slide 40: Thank You

    Contact Information Company : Investor Relations Advisor : Transpek Industry Limited Strategic Growth Advisors Pvt. Ltd. CIN: L23205GJ1965PLC001343 CIN: U74140MH2010PTC204285 Mr. Alak D. Vyas Mr. Shrikant Sangani / Ms. Pankti Majithia E: shrikant.sangani@sgapl.net / pankti.majithia@sgapl.net E: secr

Transpek Industry — Investor Presentation (November 2022) on 6ix